Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody (Q45236555)

11 December 2017

Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody (English)

1 reference

11 December 2017

1 reference

1 reference

1 reference

Kazuhiko Kasuya

1

1 reference

11 December 2017

Julie L Boyer

2

1 reference

11 December 2017

Yadi Tan

3

1 reference

11 December 2017

D Olivier Alipui

4

1 reference

11 December 2017

Neil R Hackett

5

1 reference

11 December 2017

Ronald G Crystal

6

1 reference

11 December 2017

1 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

11

1 reference

11 December 2017

2

1 reference

11 December 2017

237-244

1 reference

Molecular pathogenesis of Bacillus anthracis infection

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Anthrax as a biological weapon, 2002: updated recommendations for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Germination of Bacillus anthracis spores within alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Bacillus anthracis, a bug with attitude!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Understanding Bacillus anthracis pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Development of an improved vaccine for anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

In vitro correlate of immunity in a rabbit model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Passive antibody administration (immediate immunity) as a specific defense against biological weapons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Passive immunity in prevention and treatment of infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Passive transfer of protection against Bacillus anthracis infection in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Search for correlates of protective immunity conferred by anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Human antibodies from immunized donors are protective against anthrax toxin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Microbiology. A binding contract for anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Human recombinant neutralizing antibodies against hantaan virus G2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Genetically engineered intracellular single-chain antibodies in gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

High In Vivo Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Recombinant adenoviruses as vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Adenoviruses as gene-delivery vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Replication-defective vector based on a chimpanzee adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Development of adenovirus serotype 35 as a gene transfer vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2004.10.018

1 reference

11 December 2017

1 reference